PREVENTION OF IFOSFAMIDE-INDUCED HEMORRHAGIC CYSTITIS BY CONTINUOUS BLADDER IRRIGATION

被引：1
|
作者：
FUJITA, J [1 ]
MATSUMOTO, K [1 ]
KAKIZOE, T [1 ]
MURASE, T [1 ]
机构：
[1] NATL CANC CTR HOSP,DIV UROL,TOKYO,JAPAN
来源：
UROLOGY | 1981年 / 18卷 / 03期
关键词：
D O I：
10.1016/0090-4295(81)90356-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：250 / 251
页数：2
相关论文
共 50 条
  • [31] Effectiveness of Exogenous Albumin Administration for the Prevention of Ifosfamide-Induced Encephalopathy
    Kettle, Jacob K.
    Grauer, Dennis
    Folker, Tanya L.
    O'Neal, Nyla
    Henry, David W.
    Williams, Casey B.
    PHARMACOTHERAPY, 2010, 30 (08): : 812 - 817
  • [32] The Effect of Acetylcysteine on Renal Function in Experimental Models of Cyclophosphamide-and Ifosfamide-Induced Cystitis
    不详
    CURRENT UROLOGY, 2021, 15 (04)
  • [33] PREVENTION OF HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT PREPARATIVE REGIMENS WITH CYCLOPHOSPHAMIDE AND BUSULFAN - ROLE OF CONTINUOUS BLADDER IRRIGATION
    TURKERI, LN
    LUM, LG
    UBERTI, JP
    ABELLA, E
    MOMIN, F
    KARANES, C
    SENSENBRENNER, LL
    HAAS, GP
    JOURNAL OF UROLOGY, 1995, 153 (03): : 637 - 640
  • [34] Recurrent ifosfamide-induced hyponatraemia
    Kirch, C
    Gachot, B
    Germann, N
    Blot, F
    Nitenberg, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (14) : 2438 - 2439
  • [35] IFOSFAMIDE-INDUCED HYPERPIGMENTATION - REPLY
    TERESI, ME
    MURRY, DJ
    CORNELIUS, AS
    CANCER, 1994, 73 (01) : 241 - 241
  • [36] Correction to: α-Phellandrene attenuates tissular damage, oxidative stress, and TNF-α levels on acute model ifosfamide-induced hemorrhagic cystitis in mice
    R. L. G. Gonçalves
    F. V. M. Cunha
    B. P. S. Sousa-Neto
    L. S. A. Oliveira
    M. E. Lopes
    D. C. Rezende
    I. J. O. Sousa
    K. M. Nogueira
    L. K. M. Souza
    J. V. R. Medeiros
    D. V. T. Wong
    V. M. P. Pereira
    R. C. P. Lima-Júnior
    D. P. Sousa
    C. P. C. Oliveira
    F. R. C. Almeida
    Francisco de Assis Oliveira
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 2553 - 2554
  • [37] IFOSFAMIDE-INDUCED URINARY-BLADDER LESION AND ITS INHIBITION BY MESNA
    MURAOKA, Y
    WATANABE, H
    MATSUI, S
    NARA, H
    KASAI, H
    FOLIA PHARMACOLOGICA JAPONICA, 1990, 96 (02) : 73 - 83
  • [38] Ifosfamide-Induced Tubuler Dysfunction
    Tokuc, G.
    Eker, N.
    Senay, E.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S171 - S171
  • [39] IFOSFAMIDE-INDUCED FANCONI SYNDROME
    GARCIA, AA
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (06) : 590 - 591
  • [40] DOWNREGULATION OF PRO-INFLAMMATORY PATHWAYS BY IPSE, A UROGENITAL PARASITE-DERIVED IMMUNOMODULATORY PROTEIN, REDUCES IFOSFAMIDE-INDUCED HEMORRHAGIC CYSTITIS
    Mbanefo, Evaristus
    Le, Loc
    Zee, Rebecca
    Banskota, Nirad
    Ishida, Kenji
    Pennington, Luke
    Odegaard, Justin
    Jardetzky, Theodore
    Alouffi, Abdulaziz
    Falcone, Franco
    Hsieh, Michael
    JOURNAL OF UROLOGY, 2019, 201 (04): : E691 - E692
12345